Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Antenatal screening practice for infectious diseases by general practitioners in Australia

Giles ML, Pedrana A, Jones C, Garland S, Hellard M, Lewin SR

(2009), Aust N Z J Obstet Gynaecol, 49(1), 39-44

The "work" of women when considering and using interventions to reduce mother-to-child transmission (MTCT) of HIV

Giles ML, Hellard ME, Lewin SR, O'Brien ML

(2009), AIDS Care, 21(10), 1230-7

Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy

Elliott JH, Vohith K, Saramony S, Savuth C, Dara C, Sarim C, Huffam S, Oelrichs R, Sophea P, Saphonn V, Kaldor J, Cooper DA, Chhi Vun M, French MA

(2009), J Infect Dis, 200(11), 1736-45

Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: the Asia Pacific HIV Observational Database (APHOD)

Egger S, Petoumenos K, Kamarulzaman A, Hoy J, Sungkanuparph S, Chuah J, Falster K, Zhou J, Law MG; Asia Pacific HIV Observational Database (APHOD)

(2009), J Acquir Immune Defic Syndr, 50(5), 513-20

Lipoprotein particle subclasses, cardiovascular disease and HIV infection

Duprez DA, Kuller LH, Tracy R, Otvos J, Cooper DA, Hoy J, Neuhaus J, Paton NI, Friis-Moller N, Lampe F, Liappis AP, Neaton JD; INSIGHT SMART Study Group

(2009), Atherosclerosis, 207(2), 524-9

HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection

Denholm JT, Wright EJ, Street A, Sasadeusz JJ

(2009), Haemophilia, 15(2), 538-43

Community acquisition of ESBL-producing Escherichia coli: a growing concern

Denholm JT, Huysmans M, Spelman D

(2009), Med J Aust, 190(1), 45-6

Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study

Davis JS, Yeo TW, Thomas JH, McMillan M, Darcy CJ, McNeil YR, Cheng AC, Celermajer DS, Stephens DP, Anstey NM

(2009), Crit Care, 13(5), R155

Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy

Crane M, Oliver B, Matthews G, Avihingsanon A, Ubolyam S, Markovska V, Chang JJ, Dore GJ, Price P, Visvanathan K, French M, Ruxrungtham K, Lewin SR

(2009), J Infect Dis, 199(7), 974-81

Age and height predict neuropathy risk in patients with HIV prescribed stavudine

Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S, Kamarulzaman A, Price P

(2009), Neurology, 73(4), 315-20

Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis

Cheng AC, McBryde ES, Wuthiekanun V, Chierakul W, Amornchai P, Day NP, White NJ, Peacock SJ

(2009), Antimicrob Agents Chemother, 53(10), 4193-9

Delayed administration of antibiotics and mortality in patients with community-acquired pneumonia

Cheng AC, Buising KL

(2009), Ann Emerg Med, 53(5), 618-24

Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection

Chang JJ, Sirivichayakul S, Avihingsanon A, Thompson AJ, Revill P, Iser D, Slavin J, Buranapraditkun S, Marks P, Matthews G, Cooper DA, Kent SJ, Cameron PU, Sasadeusz J, Desmond P, Locarnini S, Dore GJ, Ruxrungtham K, Lewin SR

(2009), J Virol, 83(15), 7649-58

Fatal acute varicella-zoster virus hemorrhagic meningomyelitis with necrotizing vasculitis in an HIV-infected patient

Chang CC, McLean C, Vujovic O, Jenney AJ, Short M, Lyon S, Storey E, Lewin SR

(2009), Clin Infect Dis, 48(3), 372-3

Neurodegeneration and ageing in the HAART era

Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G

(2009), J Neuroimmune Pharmacol, 4(2), 163-74

Ross River virus

Barber B, Denholm JT, Spelman D

(2009), Aust Fam Physician, 38(8), 586-9

Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations

Audsley J, Arrifin N, Yuen LK, Ayres A, Crowe SM, Bartholomeusz A, Locarnini SA, Mijch A, Lewin SR, Sasadeusz J

(2009), HIV Med, 10(4), 229-35

Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96

Arastéh K, Yeni P, Pozniak A, Grinsztejn B, Jayaweera D, Roberts A, Hoy J, De Meyer S, Vangeneugden T, Tomaka F

(2009), Antivir Ther, 14(6), 859-64

A randomized, placebo-controlled, dose-escalation study to determine the safety, tolerability, and immunogenicity of an HPV-16 therapeutic vaccine in HIV-positive participants with oncogenic HPV infection of the anus

Anderson JS, Hoy J, Hillman R, Barnden M, Eu B, McKenzie A, Gittleson C

(2009), J Acquir Immune Defic Syndr, 52(3), 371-81

Bacteriology and management of necrotizing soft tissue infections

Abbott IJ, Spelman D

(2009), J Emerg Med, 37(4), 420-1

686 687 688 689 690